Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
- PMID: 20652047
- PMCID: PMC2905918
- DOI: 10.1155/2010/170393
Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
Abstract
Diabetic complications are a leading cause of acquired blindness, end-stage renal failure, and accelerated atherosclerosis, which are associated with the disabilities and high mortality rates seen in diabetic patients. Continuous hyperglycemia is involved in the pathogenesis of diabetic micro- and macrovascular complications via various metabolic pathways, and numerous hyperglycemia-induced metabolic and hemodynamic conditions exist, including increased generation of various types of advanced glycation end-products (AGEs). Recently, we demonstrated that glyceraldehyde-derived AGEs, the predominant structure of toxic AGEs (TAGE), play an important role in the pathogenesis of angiopathy in diabetic patients. Moreover, recent evidence suggests that the interaction of TAGE with the receptor for AGEs (RAGE) elicits oxidative stress generation in numerous types of cells, all of which may contribute to the pathological changes observed in diabetic complications. In this paper, we discuss the pathophysiological role of the TAGE-RAGE system in the development and progression of diabetic retinopathy.
Figures


Similar articles
-
Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.Curr Drug Targets. 2010 Nov;11(11):1468-82. doi: 10.2174/1389450111009011468. Curr Drug Targets. 2010. PMID: 20583971 Review.
-
TAGE (toxic AGEs) theory in diabetic complications.Curr Mol Med. 2006 May;6(3):351-8. doi: 10.2174/156652406776894536. Curr Mol Med. 2006. PMID: 16712480 Review.
-
Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.Med Hypotheses. 2015 May;84(5):490-3. doi: 10.1016/j.mehy.2015.02.002. Epub 2015 Feb 10. Med Hypotheses. 2015. PMID: 25697114
-
Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.World J Hepatol. 2014 Dec 27;6(12):880-93. doi: 10.4254/wjh.v6.i12.880. World J Hepatol. 2014. PMID: 25544875 Free PMC article. Review.
-
Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease.J Alzheimers Dis. 2009;16(4):845-58. doi: 10.3233/JAD-2009-0974. J Alzheimers Dis. 2009. PMID: 19387117 Review.
Cited by
-
RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells.Sci Rep. 2021 Feb 3;11(1):2959. doi: 10.1038/s41598-021-82619-0. Sci Rep. 2021. PMID: 33536515 Free PMC article.
-
Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle.Diabetol Metab Syndr. 2020 Nov 30;12(1):105. doi: 10.1186/s13098-020-00614-3. Diabetol Metab Syndr. 2020. PMID: 33292465 Free PMC article. Review.
-
Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.Diagnostics (Basel). 2016 Jun 7;6(2):23. doi: 10.3390/diagnostics6020023. Diagnostics (Basel). 2016. PMID: 27338481 Free PMC article. Review.
-
Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.J Clin Biochem Nutr. 2015 Jul;57(1):1-12. doi: 10.3164/jcbn.15-3. Epub 2015 Jul 1. J Clin Biochem Nutr. 2015. PMID: 26236094 Free PMC article. Review.
-
Mechanism and implications of advanced glycation end products (AGE) and its receptor RAGE axis as crucial mediators linking inflammation and obesity.Mol Biol Rep. 2025 Jun 5;52(1):556. doi: 10.1007/s11033-025-10632-x. Mol Biol Rep. 2025. PMID: 40474023 Review.
References
-
- Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48(5):937–942. - PubMed
-
- Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787–790. - PubMed
-
- Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–820. - PubMed
LinkOut - more resources
Full Text Sources